BioSpace News Archive

The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artifici

AIDS Healthcare Foundation (AHF) called the recent announcement that Cambridge, Massachusetts-based biotechnology company Moderna has declared that it will not enforce its patent rights for its COVID-19 vaccine candidate during the pandemic if it gets approval from the U.S. Food and Drug Administration (FDA) a “positive development.”

The National Institute on Aging (NIA) has awarded Cayman Chemical with a Phase II Small Business Innovation Research (SBIR) grant to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies.

Foresee Pharmaceuticals Co., Ltd. (6576.TWO) (“Foresee”) announced today that the 505(b)(2) New Drug Application (NDA) for FP-001 LMIS 50mg, or CAMCEVI™ 42MG, a ready-to-use 6-month depot formulation of leuprolide mesylate, has been accepted for review by the U.S. Food and Drug Administration (FDA). In its Day-74 letter, the FDA stated tha

Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug Administration (FDA) has granted two Orphan Drug Designations (ODDs) to two of the

Cipher Pharmaceuticals Inc. announced the voting results for the election of directors at its Annual Meeting of Shareholders held earlier.

With a $500,000 Research Grant from Alliance for Cancer Gene Therapy (ACGT), Sidi Chen, PhD, assistant professor in the Department of Genetics and Systems Biology Institute at Yale School of Medicine and member of Yale Cancer Center, will advance a versatile and highly scalable strategy he’s been developing and calling MAEGI -- Multiplexed Activation of Endogenous Genes as an Immunotherapy.

Active wheelchairs resemble most of the sports wheelchairs available in the market and are easy to maneuver.

The growth of the global d-dimer testing market is ascribed to its high demand across the globe.

Improving patient’s health and safety is always a primary objective in hospital and health care settings, and pharmacologists have been discovering a variety of policies and technologies to achieve this objective.